We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Industry Insights

Human hand holding a green Earth surrounded by trees.
Industry Insight

Leading by Example, Challenging the Sustainability Mindset

We spoke to Darlene Solomon to learn more about improving sustainability in science and Agilent’s commitment to My Green Lab and other sustainability initiatives.
Whirling patterns of colored light.
Industry Insight

Meet the Team Who Want To Develop Psychedelics Without the Hallucinations

There remains an active debate within the psychedelic community about the importance of psychedelic experiences to these drugs’ therapeutic effects. Delix Therapeutics is developing compounds, called psychoplastogens, that act similarly to psychedelic compounds at the molecular level but do not induce hallucinations. We spoke with the Delix team to find out more about their research's progress.
Industry Insight

Using Data Lineage and Traceability to Optimize Publishing Potential

This article discusses the importance of data lineage and traceability for academic labs looking to maximize their publishing potential.
Industry Insight

The Battle for Psychedelic Patents

In this article, Technology Networks speaks with Mindset Pharma CEO James Lanthier about how patents work in the fast-changing psychedelics industry, what makes a patent effective and how newer compounds stack up against natural psychedelics.





Industry Insight

Psilocybin Study To Investigate the Serotonin System in Autism

In this interview, we speak to research scientist Tobias Whelan, who is conducting a first-ever mechanistic study of psilocybin in autistic adults to understand how the serotonin system may differ in autistic and non-autistic individuals.
Industry Insight

Developing Therapeutics To Combat ALS

In this interview, we speak to Alon Ben-Noon, CEO and co-founder of Neurosense Therapeutics to hear about the impact their drug development strategy is having on the ALS field.
Industry Insight

Exploring the Ethical Challenges of Brain–Computer Interface Technology

This article explores the current state of brain-computer interface technology and some of the ethical considerations associated with its use.
Industry Insight

Research Collaboration Yields New Treatment Possibilities for ALS

Frank Pun discusses how scientists from Insilico Medicine identified numerous unreported potential therapeutic targets of amyotrophic lateral sclerosis using the company’s proprietary AI-enabled biological target discovery platform.
Industry Insight

Alzheimer’s Breakthrough: A Disruptive Systemic Approach Is Poised To Demonstrate Value

Today’s treatments for AD are limited and unsatisfactory. This article explores a drug development effort that is taking a completely different approach – not trying to cure the disease but actually repair the damage.
Industry Insight

Harnessing AI as a Wellness Tool for Teenagers’ Mental Health

To learn more about Kai – an AI-powered personal guide and companion – and the potential benefits of using AI as a wellness tool for mental health, Technology Networks spoke to Alex Frenkel.
Advertisement